Geographic · Tax Benefit Amount

Other countries — Tax Benefit Amount

Edwards Lifesciences Other countries — Tax Benefit Amount increased by 17.0% to $104.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.0%, from $89.30M to $104.50M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

An increase indicates improved tax efficiency or higher utilization of regional tax incentives.

Detailed definition

The specific tax benefit recognized in the financial statements derived from operations in international regions outside...

Peer comparison

Commonly reported as part of the geographic tax rate reconciliation in annual reports.

Metric ID: ew_segment_other_countries_tax_benefit_amount

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$60.10M$65.50M$71.60M$89.30M$104.50M
QoQ Change+9.0%+9.3%+24.7%+17.0%
YoY Change+9.0%+9.3%+24.7%+17.0%
Range$60.10M$104.50M
CAGR+73.9%
Avg YoY Growth+15.0%
Median YoY Growth+13.2%
Current Streak4+ quarters growth

Frequently Asked Questions

What is Edwards Lifesciences's other countries — tax benefit amount?
Edwards Lifesciences (EW) reported other countries — tax benefit amount of $104.50M in Q4 2025.
How has Edwards Lifesciences's other countries — tax benefit amount changed year-over-year?
Edwards Lifesciences's other countries — tax benefit amount increased by 17.0% year-over-year, from $89.30M to $104.50M.
What does other countries — tax benefit amount mean?
The reduction in tax expense attributed to operations in international regions.